Carcinoma of the breast in postmenopausal hormone user and nonuser control groups.

  title={Carcinoma of the breast in postmenopausal hormone user and nonuser control groups.},
  author={Rafael Squitieri and Paul Ian Tartter and Saood Ahmed and Steven Brower and Neil D. Theise},
  journal={Journal of the American College of Surgeons},
  volume={178 2},
The risk and prognosis of patients with carcinoma of the breast exposed to postmenopausal hormones are controversial. Carcinoma of the breast from 35 postmenopausal women who had taken hormones were compared with carcinomas from age and histologic matched postmenopausal women who had never taken hormones. Hormone users averaged 1.1 fewer pregnancies (p < 0.005) and 1.4 fewer live births (p < 0.0005). In addition, the carcinomas had significantly lower S-phase fractions (5.36 versus 6.77, p > 0… CONTINUE READING

From This Paper

Topics from this paper.


Publications citing this paper.
Showing 1-10 of 11 extracted citations

Prediagnostic use of hormone therapy and mortality after breast cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology • 2008
View 1 Excerpt

The influence of hormone replacement therapy on the pathology of breast cancer.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology • 2005

Progestins and breast cancer.

American journal of obstetrics and gynecology • 2003

Similar Papers

Loading similar papers…